Anadolu Medical Center
Anadolu Medical Center
Turquie, Istanbul
Bulent Karagoz
33 années d'expérience
La clinique est certifiée :
Le coût du traitement du mélanome en Turquie peut varier en fonction du plan de traitement sélectionné. Une consultation avec un oncologue radiothérapeute coûte 188 €, et 5 fractions de radiochirurgie stéréotaxique (SRS) sont au prix de 6 110 €. Une IRM du cerveau avec contraste coûte 705 €. Un scanner TEP-TDM est à 658 €, et un test de mutation BRAF est d"environ 1 693 €. Le traitement par immunothérapie, composé de trois cures, commence à 5 270 € pour la première cure et 5 175 € pour chacune des suivantes. Le plan de traitement est personnalisé en fonction des besoins du patient et de l"évaluation du médecin.
Plus de 900 interventions contre le mélanome réalisées – Le Dr Bülent Karagöz est spécialisé en immunothérapie et en thérapies ciblées au centre médical Anadolu.
Le professeur Eda Tanrikulu, MD, est spécialisée dans le mélanome malin métastatique et occupe un rôle de premier plan dans l'évaluation des cas de cancer au centre médical Anadolu.
Mustafa Solak a réalisé plus de 1 100 traitements contre le cancer, y compris le mélanome, à l'hôpital Hisar Intercontinental.
Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.
Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.
Turkish oncology centers offer integrated melanoma treatments including wide local excision, Mohs microsurgery, and immunotherapy with drugs like Keytruda. JCI-accredited facilities follow international NCCN protocols. Specialized options such as Actinium-225 therapy and Natural Killer cell therapy are also available for advanced cases in Istanbul.
Bookimed Expert Insight: Anadolu Medical Center stands out because it is the only Turkish facility affiliated with Johns Hopkins Medicine. It integrates OECI-accredited cancer care with high patient volumes of 65,000 annually. This combination of American medical standards and high-frequency surgical experience typically results in more refined diagnostic histopathology revisions.
Patient Consensus: Patients emphasize the importance of having personal coordinators who handle the complex logistics of multi-day immunotherapy cycles. Many note that the multidisciplinary team approach helps them feel more confident during recovery.
Top-tier melanoma care in Turkey is concentrated in JCI-accredited centers like Anadolu Medical Center and Memorial Şişli Hospital. These facilities offer multidisciplinary treatments. Patients access advanced immunotherapy like Keytruda and precision diagnostics. Leading specialists often hold American or European board certifications.
Bookimed Expert Insight: Data shows a clear trend where top-rated Istanbul clinics leverage international affiliations for complex melanoma cases. Anadolu Medical Center serves 65,000 patients annually through its Johns Hopkins partnership. For advanced staging, look for centers with Digital PET/CT technology, like Istanbul Florence Nightingale Hospital. This equipment is vital for detecting small metastases that standard scans might miss.
Patient Consensus: Patients note that the depth of the medical team is vital. They appreciate having oncologists and plastic surgeons plan the surgery together to ensure both clear margins and good aesthetic results.
Leading melanoma specialists in Turkey include medical oncologists and surgeons at JCI-accredited centers in Istanbul. Experts like Dr. Bulent Karagoz and Dr. Yesim Yildirim specialize in advanced immunotherapy and targeted therapies. These physicians collaborate with specialists from Johns Hopkins Medicine to provide international treatment standards.
Bookimed Expert Insight: Anadolu Medical Center stands out for melanoma care due to its dual OECI and ESMO accreditations. While many clinics offer standard surgery, this facility integrates Johns Hopkins-level diagnostics like Digital PET/CT and BRAF gene mutation analysis. This high-tech infrastructure supports 65,000 annual patients and facilitates complex systemic therapies often unavailable at smaller surgical centers.
Patient Consensus: Patients note it is important to choose clinics like Anadolu where oncology teams work alongside plastic surgeons. They emphasize that coordinating reconstructive surgery during the initial tumor removal leads to much better aesthetic results.
Early-stage melanoma treated in Turkish oncology centers shows survival rates between 98% and 100%. These facilities achieve a 90% five-year survival rate for localized cases. Advanced metastatic melanoma survival has reached 50% through immunotherapy. Results align with international standards set by JCI-accredited institutions.
Bookimed Expert Insight: Turkish oncology centers like Anadolu Medical Center maintain a high standard of care through their direct affiliation with Johns Hopkins Hospital. This partnership ensures that patients receive the same treatment protocols used in the United States. With over 65,000 patients treated annually at this facility, the high volume of cases contributes to a refined expertise in complex surgeries like Mohs micrographic surgery and advanced Actinium-225 therapies.
Patient Consensus: Patients often mention that the coordinated care between surgeons and oncologists makes the treatment process much smoother. Many note that having access to advanced drugs like Keytruda in Turkey provides a sense of relief when standard treatments are not enough.
Travel is generally safe 10 to 14 days after melanoma surgery once initial healing begins. Most experts recommend waiting 7 to 10 days for short flights. Long-haul travel should be delayed for at least 2 to 3 weeks to minimize blood clot risks.
Bookimed Expert Insight: Turkish oncology centers often use a multidisciplinary approach involving both plastic surgeons and oncologists. For instance, Dr. Haluk Duman at Anadolu Medical Center specializes in skin tumor surgeries with 35+ years of experience. This collaboration ensures that reconstructive needs are met alongside oncology standards, which can streamline the recovery timeline for international patients.
Patient Consensus: Patients note that flying too early can cause painful swelling and bandage complications. They emphasize wearing compression sleeves and scheduling a local dermatology visit within two weeks of returning home.